James W F Catto
Overview
Explore the profile of James W F Catto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
6337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Birtle A, Jones R, Chester J, Lewis R, Biscombe K, Johnson M, et al.
J Clin Oncol
. 2024 Feb;
42(13):1466-1471.
PMID: 38350047
JCO POUT was a phase III, randomized, open-label trial, including 261 patients with muscle-invasive or lymph node-positive, nonmetastatic upper tract urothelial cancer (UTUC) randomly assigned after radical nephroureterectomy to platinum-based...
12.
Donovan J, Hamdy F, Athene Lane J, Young G, Metcalfe C, Walsh E, et al.
NEJM Evid
. 2024 Feb;
2(4):EVIDoa2300018.
PMID: 38320051
BACKGROUND: Long-term patient-reported outcomes are needed to inform treatment decisions for localized prostate cancer. METHODS: Patient-reported outcomes of 1643 randomly assigned participants in the ProtecT (Prostate Testing for Cancer and...
13.
Gore J, Follmer K, Reynolds J, Nash M, Anderson C, Catto J, et al.
Urol Oncol
. 2023 Dec;
42(4):116.e17-116.e21.
PMID: 38087711
Background: Academic and community urology centers participating in a pragmatic clinical trial in non-muscle-invasive bladder cancer completed monthly surveys assessing restrictions in aspects of bladder cancer care due to the...
14.
Rogers Z, Glaser A, Catto J, Bottomley S, Jubber I, Kotwal S, et al.
BJU Int
. 2023 Nov;
133(4):460-473.
PMID: 38031657
Objectives: To describe the health-related quality of life (HRQoL) of patients in a prospective 12-month observational cohort study of new bladder cancer diagnoses and compare with national cancer and general...
15.
Khetrapal P, Bains P, Jubber I, Ambler G, Williams N, Brew-Graves C, et al.
Eur Urol Oncol
. 2023 Oct;
7(3):485-493.
PMID: 37852921
Background: Efforts to improve recovery after radical cystectomy (RC) are needed. Objective: To investigate wrist-worn wearable activity trackers in RC participants. Design, Setting, And Participants: An observational cohort study was...
16.
Khetrapal P, Wong J, Tan W, Rupasinghe T, Tan W, Williams S, et al.
Eur Urol
. 2023 Aug;
84(4):e98-e99.
PMID: 37562989
No abstract available.
17.
Conroy S, Catto J, Bex A, Brown J, Cartledge J, Fielding A, et al.
BJU Int
. 2023 Jul;
132(5):541-553.
PMID: 37436368
Objectives: To report the NHS Digital (NHSD) data for patients diagnosed with kidney cancer (KC) in England. We explore the incidence, route to diagnosis (RTD), treatment, and survival patterns from...
18.
Dixon S, Hill H, Flight L, Khetrapal P, Ambler G, Williams N, et al.
JAMA Netw Open
. 2023 Jun;
6(6):e2317255.
PMID: 37389878
Importance: The value to payers of robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC) when compared with open radical cystectomy (ORC) for patients with bladder cancer is unclear. Objectives: To...
19.
Jubber I, Morhardt D, Griffin J, Cumberbatch M, Glover M, Zheng Y, et al.
Dis Model Mech
. 2023 Jun;
16(7).
PMID: 37293698
Little is known about the distal excretory component of the urinary tract in Danio rerio (zebrafish). This component is affected by many human diseases and disorders of development. Here, we...
20.
Jubber I, Ong S, Bukavina L, Black P, Comperat E, Kamat A, et al.
Eur Urol
. 2023 May;
84(2):176-190.
PMID: 37198015
Context: Bladder cancer (BC) is common worldwide and poses a significant public health challenge. External risk factors and the wider exposome (totality of exposure from external and internal factors) contribute...